The 2018 NDAA includes the incorporation of V-BID principles within Section 702 – Modifications of cost-sharing requirements for the TRICARE Pharmacy Benefits Program and treatment of certain pharmaceutical agents. The pilot includes an evaluation of how reducing or eliminating the cost-sharing for specified high-value medications and services impacts: (I) adherence to medication regimens; (II) quality measures; (III) health outcomes; and (IV) beneficiary experience. National Defense Authorization Act for Fiscal Year 2018
National Defense Authorization Act for Fiscal Year 2017
